ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
Sales | -146 | 1,810 | 51 | 32 | 40 |
Gross Profit | -146 | 1,810 | 51 | 32 | 40 |
Operating Expenses | 1,440 | 1,461 | 910 | 722 | 980 |
Operating Income | -1,586 | 349 | -859 | -690 | -940 |
Other Income | 174 | 0 | 0 | 0 | 10 |
Pre-tax Income | -1,412 | 349 | -859 | -690 | -930 |
Net Income Continuous | -1,412 | 349 | -859 | -690 | -930 |
Net Income | $-1,412 | $349 | $-859 | $-690 | $-930 |
EPS Basic Total Ops | -7.92 | 1.80 | -4.68 | -3.60 | -7.20 |
EPS Basic Continuous Ops | -7.40 | 1.87 | -4.65 | -4.31 | -5.78 |
EPS Diluted Total Ops | -7.56 | 1.44 | -4.68 | -3.60 | -7.20 |
EPS Diluted Continuous Ops | -7.12 | 1.59 | -4.65 | -4.31 | -5.78 |
EBITDA(a) | $-1,564 | $371 | $-834 | $-666 | $-893 |